Early molecular genetic studies of AD, PD and FTD provided justification for the latter approach because APP mutations can cause dementia, α-synuclein mutations can cause PD and Tau mutations can cause FTD; the affected individuals exhibit predominantly Aβ, α-synuclein and Tau pathologies, respectively. The gene discussed is MAPT; the disease is dementia.